Discover the current status of gabapentin scheduling as a controlled substance across the US and the PDMP requirements for each state. Valuable insights for healthcare providers. In the state of Kentucky, prescribers without a DEA license are unable to prescribe gabapentin after it was classified as a Schedule V controlled substance. 38 This licensing requirement is part of the state’s Controlled Substances Act which had the greatest impact on mid-level practitioners who may not have a DEA license. Kentucky gabapentin. The effect of adding these nine drugs to that list will require pharmacies dispensing these drugs to include those dispensing transactions in their automated reports to the state PMP. (b) Notwithstanding the prescription requirements for Schedule V controlled dangerous substances as provided for in R.S. 40:978(C), nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine may be dispensed without a prescription. requirement of two drugs of concern (promethazine in oral liquid formulations and gabapentin containing products) as of January 20, 2021. There is a continued downward trend in the number of opioid and controlled dangerous substance prescription dispensations to Louisiana patients. Hydrocodone bitartrate/acetaminophen remains the number one RS 40:963 - Schedules of controlled dangerous substances. There are established five schedules of controlled substances, to be known as Schedules I, II, III, IV, and V. Such schedules shall initially consist of the substances listed in R.S. 40:964. Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970.11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored PMP are compared with Controlled Dangerous Substances (CDS). The CDS prescriptions include all federally scheduled 2 through 5 prescriptions. It does not include Louisiana only scheduled prescriptions, drugs of concern, or therapeutic marijuana recommendations. From the year 2016 through 2020, Louisiana saw a 17% decrease in the number of CDS Physicians (whether allopathic [MD] or osteopathic [DO]), surgeons, and podiatrists [DPM] are licensed and regulated by the Louisiana State Board of Medical Examiners. They have been authorized by the legislature to prescribe controlled substances; that authorization is evident in the Controlled Dangerous Substance (CDS) License issued to them by the Louisiana Board of Pharmacy. (1) To produce, manufacture, distribute, or dispense or possess with intent to produce, manufacture, distribute, or dispense, a controlled dangerous substance or controlled substance analogue classified in Schedule II. In addition, a federal rule became effective August 18, 2014 which places tramadol (Ultram) products into Schedule IV of the federal list of controlled substances. This product was previously a non-controlled substance and can no longer be prescribed by APRNs in Louisiana for the management of chronic, non-cancer related pain. §963. Schedules of controlled dangerous substances P.O. Box 94062 (900 North Third Street) Baton Rouge, Louisiana 70804-9062 Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. RS 40:978 - Prescriptions. A. Except when dispensed or administered directly by a medical practitioner or administered by a person authorized to administer by such practitioner, other than a pharmacist, to an ultimate user, no controlled dangerous substance included in Schedule II, which is a prescription drug as determined under the Louisiana Revised Statutes of 1950, may be dispensed or gabapentin has been increasingly encountered by law enforcement, documented in national crime lab reports, reported to poison control centers, and diverted for illicit use. Gabapentin isn’t considered a controlled substance by the federal government. But several states have passed their own laws limiting the prescribing and sale of it. Eight states have made gabapentin a schedule V controlled substance. Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). In addition, a federal rule became effective August 18, 2014 which places tramadol (Ultram) products into Schedule IV of the federal list of controlled substances. This product was previously a non-controlled substance and can no longer be prescribed by APRNs in Louisiana for the management of chronic, non-cancer related pain. Explore Louisiana's Schedule 2 drug laws, including classifications, legal criteria, penalties, and possible defenses. Louisiana’s legal framework around Schedule 2 drugs is a crucial aspect of its drug policy, reflecting national concerns about controlled substances. RS 40:963 - Schedules of controlled dangerous substances. There are established five schedules of controlled substances, to be known as Schedules I, II, III, IV, and V. Such schedules shall initially consist of the substances listed in R.S. 40:964.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | ![]() |